Swiss medical device developer whose cervical stiffness measurement system supports pregnancy care and premature birth risk assessment.
Pregnolia AG, founded in 2016 in Schlieren, Switzerland, develops devices that measure cervical stiffness to help clinicians assess risks linked to premature birth. The system is based on research from ETH Zürich and University Hospital Zürich, carries CE certification, and is sold directly to hospitals and clinics in selected European markets. The company has completed 6 deals. In March 2026 it received an undisclosed grant from the European Innovation Council, part of a larger CHF 3.4 million equity and grant fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in